Abstract

Innate lymphoid cells (ILCs) are specialized immune cells that rapidly respond to environmental challenges, such as infection and tissue damage. ILCs play an important role in organ homeostasis, tissue repair, and host defense in the mucosal tissues intestine and lung. ILCs are sentinels of healthy tissue function, yet it is poorly understood how ILCs are recruited, strategically positioned, and maintained within tissues. Accordingly, ILC migration is an area that has recently come into focus and it is important to define the signals that control ILC migration to and within tissues. In this context, signals from the local tissue microenvironment are relevant. For example, ILCs in the intestine are exposed to an environment that is rich in dietary, microbial, and endogenous metabolites. It has been shown that the Vitamin A metabolite retinoic acid promotes ILC1 and ILC3 homing to the intestine. In addition, recent studies have discovered cholesterol metabolites (oxysterols) as a novel class of molecules that regulate ILC migration through the receptor GPR183. ILCs are considered to be largely tissue-resident cells, yet recent data indicate that ILCs actively migrate during inflammation. Furthermore, the discovery of circulating ILC precursors in humans and their presence within tissues has fueled the concept of local ILC-poiesis. However, it is unclear how circulating ILCs enter tissue during embryogenesis and inflammation and how they are directed to local tissue niches. In this review, I will discuss the metabolic signals that regulate ILC homing and their strategic positioning in healthy and inflamed tissues. It is becoming increasingly clear that ILC function is closely linked to their tissue localization. Therefore, understanding the tissue signals that control ILC migration could open new avenues for the treatment of chronic inflammatory diseases and cancer.

Highlights

  • Innate lymphoid cells (ILCs) are immune cells of lymphoid origin that quickly respond to perturbations of tissue homeostasis

  • In addition to cytotoxic natural killer (NK) cells, three different ILC types can be distinguished based on signature transcription factors and effector cytokines, similar to CD4+ T helper lymphocytes: [1] T-BET+ ILC1s produce interferon-gamma (IFNγ); [2] GATA3high ILC2s produce interleukin-5 (IL-5) and IL-13; [3] RORγt+ ILC3s produce IL-17 and/or IL-22

  • Lymphoid tissue-resident human ILC3s with lymphoid tissue-inducer (LTi) activity, as well as murine fetal CD4+ LTi cells, express CCR6 and CXCR5, and Neuropilin-1, which mediates their migration toward vascular endothelial growth factor-A (VEGFA) [99]

Read more

Summary

Introduction

Innate lymphoid cells (ILCs) are immune cells of lymphoid origin that quickly respond to perturbations of tissue homeostasis. Lymphoid tissue-resident human ILC3s with LTi activity, as well as murine fetal CD4+ LTi cells, express CCR6 and CXCR5, and Neuropilin-1, which mediates their migration toward vascular endothelial growth factor-A (VEGFA) [99]. LTi-like ILC3s are capable of trafficking from the intestine to draining mesenteric lymph nodes in a CCR7-dependent manner [84].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call